Regional
Growth and Demand of Atherectomy Devices Market:
North America is expected to account for the largest share of the Atherectomy Devices Market in 2017, followed by Europe. Factors such as increasing availability of
reimbursements for atherectomy devices, growing adoption of atherectomy devices
among medical professionals, large patient population of peripheral &
coronary artery diseases, and growing number of clinical trials are driving the
growth of the North American atherectomy devices market.
Asia Pacific is expected to register the highest growth rate during the forecast
period. This can be attributed to the increasing prevalence of target diseases,
increasing healthcare expenditure, cost-effective (owing to the increase in
localized manufacturing and strengthening of distribution networks of key
product manufacturers), and rising awareness among surgeons related to the
benefits offered by atherectomy systems (less revascularization rates, high
efficacy, short procedural time).
The global atherectomy devices market
accounted is projected to reach $1.45 Billion by 2022 from $1.02 Billion in
2016, at a CAGR of 6.1%.
Get Crucial Industry Revenue Growth Insights | Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=133112140
Applications of Atherectomy
Devices Market:
1. Peripheral Vascular Applications
2. Cardiovascular Applications
3. Neurovascular Applications
The peripheral vascular applications segment accounted for the major share of
the market owing to the significant availability of clinical evidence to
support the therapeutic efficacy of atherectomy in PVD treatment and growing
patient preference for minimally invasive surgical procedures.
Global Market Growth Opportunities:
1. Increasing Number of Research Activities in the Field of Atherectomy
2. Increasing Healthcare Expenditure Across Emerging Markets
Atherectomy Devices Market by Products:
The directional atherectomy devices segment accounted for the largest
share of the market. It is also expected to register the highest CAGR during
the forecast period. This can be attributed to clinical benefits offered (such
as lack of barotrauma, less risk of neointimal hyperplasia, immediate change of
bypass site, and availability of differently sized instruments to enable
atherectomy in blood vessels) and ongoing technological advancements in the
field of directional atherectomy.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=133112140
Leading Players in Atherectomy
Devices Market:
Major players operating in the market are Medtronic (Ireland), Philips
(Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other
prominent players present in this market include Straub Medical (Switzerland),
BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).
